A Case of Primary Intracranial Sarcoma, DICER1-Mutant, in a Child with a Germline DICER1 Mutation

DICER1 syndrome is a tumor predisposition syndrome caused by abnormal micro-RNA processing which leads to a variety of benign and malignant neoplasms in many organ systems, including the central nervous system. This paper reports the case of a primary intracranial sarcoma, DICER1-mutant, in a patient with a germline DICER1 variant thought most likely to be de novo. The patient is a ten-year-old boy who presented acutely with altered level of consciousness, emesis, and left-sided weakness. Imaging revealed a large right frontal hemorrhagic lesion, which was urgently debulked. Histology demonstrated a high-grade sarcomatous lesion. Molecular studies revealed compound heterozygous DICER1 variants (a frame shift insertion and a missense mutation), and a KRAS missense mutation. The final pathologic diagnosis was rendered to be “primary intracranial sarcoma, DICER1-mutant”. Germline genetic testing revealed that the patient possessed a germline DICER1 variant (parental testing was negative). A dramatic reduction in tumor size was precipitated via chemotherapy (ifosfamide, carboplatin, and etoposide) and radiotherapy (focal proton beam therapy). There was no evidence of residual disease at the primary site at the end of the therapy.

[1]  H. Vuong,et al.  A systematic review of the clinicopathological features and prognostic outcomes of DICER1-mutant malignant brain neoplasms. , 2022, Journal of neurosurgery. Pediatrics.

[2]  S. Pfister,et al.  Primary central nervous system sarcoma with DICER1 mutation—treatment results of a novel molecular entity in pediatric Peruvian patients , 2021, Cancer.

[3]  D. Stewart,et al.  DICER1 tumor predisposition syndrome: an evolving story initiated with the pleuropulmonary blastoma , 2021, Modern Pathology.

[4]  D. Kessler,et al.  Stopping the beating heart of cancer: KRAS reviewed. , 2021, Current opinion in structural biology.

[5]  J. Tímár,et al.  Molecular epidemiology and diagnostics of KRAS mutations in human cancer , 2020, Cancer and Metastasis Reviews.

[6]  K. Ligon,et al.  Loss of histone H3 trimethylation on lysine 27 and nuclear expression of transducin‐like enhancer 1 in primary intracranial sarcoma, DICER1‐mutant , 2020, Histopathology.

[7]  W. Foulkes,et al.  DICER1-associated central nervous system sarcoma in children: comprehensive clinicopathologic and genetic analysis of a newly described rare tumor , 2020, Modern Pathology.

[8]  W. Foulkes,et al.  An update on the central nervous system manifestations of DICER1 syndrome , 2019, Acta Neuropathologica.

[9]  David T. W. Jones,et al.  Primary intracranial sarcomas with DICER1 mutation often contain prominent eosinophilic cytoplasmic globules and can occur in the setting of neurofibromatosis type 1 , 2019, Acta Neuropathologica.

[10]  David T. W. Jones,et al.  Primary intracranial spindle cell sarcoma with rhabdomyosarcoma-like features share a highly distinct methylation profile and DICER1 mutations , 2018, Acta Neuropathologica.

[11]  S. Bens,et al.  Multiple DICER1‐related tumors in a child with a large interstitial 14q32 deletion , 2018, Genes, chromosomes & cancer.

[12]  Gretchen M. Williams,et al.  Temporal order of RNase IIIb and loss-of-function mutations during development determines phenotype in pleuropulmonary blastoma / DICER1 syndrome: a unique variant of the two-hit tumor suppression model , 2018, F1000Research.

[13]  C. Hawkins,et al.  Successful treatment of primary intracranial sarcoma with the ICE chemotherapy regimen and focal radiation in children. , 2016, Journal of neurosurgery. Pediatrics.

[14]  Gretchen M. Williams,et al.  Temporal order of RNase IIIb and loss-of-function mutations during development determines phenotype in DICER1 syndrome: a unique variant of the two-hit tumor suppression model. , 2015, F1000Research.

[15]  W. Foulkes,et al.  DICER1: mutations, microRNAs and mechanisms , 2014, Nature Reviews Cancer.

[16]  Trevor J Pugh,et al.  Exome sequencing of pleuropulmonary blastoma reveals frequent biallelic loss of TP53 and two hits in DICER1 resulting in retention of 5p-derived miRNA hairpin loop sequences , 2014, Oncogene.

[17]  Gretchen M. Williams,et al.  DICER1 Mutations in Familial Pleuropulmonary Blastoma , 2009, Science.